Vitachemie Pharmaceuticals Private Limited

VITACHEMIE PHARMACEUTICALS: Redefining Healthcare through Affordable Excellence
​The Visionary Leadership of Vidyanand Kumar
​At the heart of Vitachemie Pharmaceuticals Private Limited is its Co-founder and CEO, Vidyanand Kumar. A dynamic and results-oriented leader, Vidyanand brings a unique "Unicorn Growth" perspective to the traditional pharmaceutical landscape. With over seven years of intensive experience in business expansion, operations, and strategic scaling, he has been a key player in the journeys of India’s most successful startups, including Swiggy and Oyo.
​Transitioning from the high-velocity world of consumer tech and hospitality to healthcare, Vidyanand is driven by a singular mission: to utilize his expertise in large-scale operations to solve the "Affordability Gap" in the Indian medical sector. Under his leadership, Vitachemie is not just another pharmaceutical company; it is a mission-driven enterprise built on the pillars of efficiency, integrity, and social impact. He believes that the same operational rigor used to deliver food or hotel stays can be applied to delivering life-saving medications to those who need them most.
​About Vitachemie Pharmaceuticals Private Limited
​Vitachemie Pharmaceuticals is a private incorporated entity (CIN: U47721BR2025PTC073935) dedicated to the manufacturing, distribution, and wholesale of high-quality pharmaceutical products. While many companies in the sector focus on premium pricing, Vitachemie focuses on High Accessibility. We operate under the firm conviction that "Premium Healthcare is a Right, Not a Luxury."
​Based in Nawada, Bihar, the company is strategically positioned to address healthcare disparities in both urban and rural India. We integrate modern operational excellence with traditional pharmaceutical rigor to improve patient outcomes nationwide.
​Our Strategic Approach: Tech-Ops Meets Pharma
​Leveraging Vidyanand's background at Swiggy and Oyo, Vitachemie employs a data-driven, efficient methodology within the pharmaceutical framework. This includes:
​Lean Supply Chain: By optimizing logistical routes and reducing unnecessary overhead, we ensure that medications remain affordable for the end consumer.
​Operational Agility: We use modern demand-forecasting tools to maintain consistent stock levels, ensuring that critical medicines are available even in remote areas.
​Quality Assurance: We adhere strictly to WHO-GMP (Good Manufacturing Practices) standards. Every product in our portfolio undergoes rigorous testing for purity, efficacy, and stability.
​Therapeutic Portfolio: Precision and Purity
​Vitachemie Pharmaceuticals focuses on high-demand therapeutic segments where quality and affordability can make the most significant impact on public health. Our current product line is recognized for its accurate composition and reliable therapeutic results:
​Gastroenterology Solutions: Our flagship formulation, ESOMCHE-D (Esomeprazole 40mg & Domperidone 30mg), provides advanced relief for GERD, gastric ulcers, and chronic acidity. It is designed for maximum bioavailability and patient comfort.
​Advanced Pain Management: CHEMLOFEN-SP combines Aceclofenac, Paracetamol, and Serratiopeptidase. This triple-action formula is highly effective for managing post-traumatic pain, inflammation, and edema.
​Nutritional & Hematology Support: We address widespread nutritional deficiencies through products like FESCORV-XT (Ferrous Ascorbate & Folic Acid) and our Calcium Carbonate & Vitamin D3 tablets, which are essential for bone health and anemia management.
​Respiratory & Allergy Care: Our portfolio includes CHEMZINE-M (Montelukast & Levocetirizine), a trusted combination for the long-term management of allergic rhinitis and asthma symptoms.
​Core Values and Corporate Responsibility
​As a "Non-government Company," Vitachemie is built on a foundation of ethical business practices. We prioritize:
​Transparency: Maintaining clear and honest communication with all stakeholders, from healthcare professionals to patients.
​Integrity: Ensuring that every batch of medicine leaving our facility meets the highest safety benchmarks.
​Social Impact: We are committed to "Healing with science, caring with integrity." Our long-term vision includes community health initiatives and awareness programs designed to educate the public on preventative care.
​The Roadmap for 2026 and Beyond
​As we progress through 2026, Vitachemie is on an aggressive growth trajectory. We are currently scouting for expansion into Chronic Care (including Diabetes and Hypertension management) and Cardiovascular health. By merging the agility of a startup with the reliability of a veteran pharmaceutical player, we aim to become a household name synonymous with "Trusted & Affordable Healthcare" across the Indian subcontinent.